10 Latest Drug Approvals in India and Internationally (2026)
| Drug Name | Company | Therapeutic Area | Date Approved | Region |
|---|
| Cypsedo (Cipepofol) | Cipla | General Anesthesia | May 29, 2026 | USA (FDA) |
| Xocova (Ensitrelvir) | Shionogi | COVID-19 Post-Exposure Prophylaxis | May 29, 2026 | USA (FDA) |
| Zaynich (Cefepime & Zidebactam) | Wockhardt | Complicated Urinary Tract Infections | May 29, 2026 | USA (FDA) |
| Decnupaz (Pivekimab Sunirine) | Deciphera | Blastic Plasmacytoid Dendritic Cell Neoplasm | May 27, 2026 | USA (FDA) |
| Hepcludex (Bulevirtide-gmod) | Myr GmbH | Chronic Hepatitis Delta Virus Infection | May 22, 2026 | USA (FDA) |
| Foundayo (Orforglipron) | Eli Lilly | Obesity/Weight Loss | April 1, 2026 | USA (FDA) |
| Awiqli (Insulin Icodec-abae) | Novo Nordisk | Type 2 Diabetes Mellitus | March 26, 2026 | USA (FDA) |
| Pembrolizumab Injection | Sun Pharma | Cancer (rDNA Origin) | March 31, 2026 | India (CDSCO) |
| Durvalumab Solution for Infusion | AstraZeneca | Cancer (rDNA Origin) | March 31, 2026 | India (CDSCO) |
| Daratumumab Concentrate for Solution for Infusion | Intas Pharmaceuticals | Cancer (rDNA Origin) | March 31, 2026 | India (CDSCO) |
Additional Recent Indian Drug Approvals (CDSCO)
| Drug Name | Company | Category | Approval Date | |
|---|
| Brexpiprazole Tablets | MSN Laboratories | New Drug | May 4, 2026 | |
| Resmetirom Tablet | Cipla Ltd | New Drug | May 4, 2026 | |
| Ivosidenib 250 mg | Servier India | New Drug | May 4, 2026 | |
| Linzagolix Tablets | Exemed Pharmaceuticals | New Drug | May 4, 2026 | |
| Polmacoxib Capsules | Precise Biopharma | New Drug | May 4, 2026 | |
| Tucatinib Tablets 150 mg | BDR Pharmaceuticals | New Drug | May 4, 2026 | |
| Quadrivalent HPV Vaccine | Serum Institute of India | Vaccine | February 26, 2026 | |
| Durvalumab | AstraZeneca | Immunotherapy Drug | 2026 | |
| Brexpiprazole Tablets | Generic Manufacturers | Antipsychotic Drug | 2026 | |
| Vonoprazan-Based Drugs | Multiple Companies | Acid-Related Disorders | 2026 | |